Predisposing factors to heart failure in diabetic nephropathy: a look at the sympathetic nervous system hyperactivity

Area of Science:

• Cardiology
• Nephrology
• Endocrinology

Background:

• Heart failure (HF) is a major cause of death, often linked to sympathetic nervous system hyperactivity.
• Diabetes mellitus (DM) prevalence is rising, increasing HF risk, particularly with diabetic nephropathy (DN).
• Diabetic cardiomyopathy, a distinct condition in DN patients, arises even without hypertension or coronary artery disease (CAD).

Purpose of the Study:

• To review the role of sympathetic nervous system hyperactivity in diabetic nephropathy.
• To explore the pathogenesis of diabetic cardiomyopathy.
• To understand the link between DM, DN, and HF.

Main Methods:

• Literature review focusing on sympathetic system hyperactivity.
• Analysis of proposed mechanisms for diabetic cardiomyopathy.
• Examination of the interplay between DM, DN, CKD, and HF.

Main Results:

• Sympathetic nervous system hyperactivity is a key feature in HF and is implicated in DM complications.
• Diabetic nephropathy contributes to HF risk through various pathways, including potential direct cardiac effects.
• Pathogenesis of diabetic cardiomyopathy involves oxidative stress, metabolic changes, mitochondrial dysfunction, RAAS activation, insulin resistance, and autonomic dysfunction.

Conclusions:

• Sympathetic nervous system hyperactivity is a significant factor in the development of heart failure in patients with diabetic nephropathy.
• Understanding these mechanisms is crucial for developing targeted therapies for diabetic cardiomyopathy and preventing HF in diabetic patients.